Drug Patent Expirations for April 2015

Drug Patent Expirations for April 2015

Tradename	Applicant	Generic Name	Patent No.
FAMVIR	Novartis	famciclovir	5,866,581*PED
FAMVIR	Novartis	famciclovir	6,124,304*PED
NUVIGIL	Cephalon	armodafinil	RE37516*PED
PROVIGIL	Cephalon	modafinil	RE37516*PED
ADVAIR HFA	Glaxo Grp Ltd	fluticasone propionate; salmeterol xinafoate	5,674,472*PED
FLOVENT HFA	Glaxo Grp Ltd	fluticasone propionate	5,674,472*PED
HYCAMTIN	Glaxosmithkline	topotecan hydrochloride	5,674,872*PED
AKYNZEO	Helsinn Hlthcare	netupitant; palonosetron hydrochloride	5,202,333
ALOXI	Helsinn Hlthcare	palonosetron hydrochloride	5,202,333
CLEVIPREX	Medicines Co	clevidipine	5,739,152
MYLOTARG	Wyeth Pharms Inc	gemtuzumab ozogamicin	5,739,116
GATTEX KIT	Nps Pharms Inc	teduglutide recombinant	5,789,379
JUXTAPID	Aegerion	lomitapide mesylate	5,739,135
EMEND	Merck	aprepitant	5,719,147
ABILIFY	Otsuka	aripiprazole	5,006,528*PED
ABILIFY MAINTENA KIT	Otsuka Pharm Co Ltd	aripiprazole	5,006,528
CAVERJECT	Pharmacia And Upjohn	alprostadil	5,741,523
EXUBERA	Pfizer	insulin recombinant human	5,740,794
OXYTROL	Watson Labs (utah)	oxybutynin	5,834,010
OXYTROL FOR WOMEN	Bayer Healthcare Llc	oxybutynin	5,834,010
OXYTROL	Watson Labs (utah)	oxybutynin	5,601,839
OXYTROL FOR WOMEN	Bayer Healthcare Llc	oxybutynin	5,601,839
LAMISIL	Novartis	terbinafine	5,681,849*PED
MAVIK	Abbvie	trandolapril	5,744,496
LAMISIL AT	Novartis	terbinafine	5,681,849*PED
LAMISIL AT	Novartis	terbinafine hydrochloride	5,681,849*PED
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.